Literature DB >> 10399970

Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment.

T E Le Voyer1, J P Hoffman, H Cooper, E Ross, E Sigurdson, B Eisenberg.   

Abstract

Lesions located in the distal third of the rectum are usually treated with abdominoperineal resection or a low anterior resection with a coloanal anastomosis. However, in a select group of patients with favorable histology and a low probability of lymphatic spread, sphincter-sparing procedures will afford long-term disease-free survival and cure without the need for extensive, complicated surgery. We performed a 10-year retrospective review, including pathologic examination of specimens by a single pathologist, in an attempt to identify factors associated with a decreased disease-free survival. Thirty-five patients (median age, 71 years; range, 48-88) with low rectal carcinomas were treated with full-thickness disc excision (with or without chemoradiation), with curative intent. Median follow-up was 46 months (range, 8-120). There were 15 T1, 16 T2, and 4 T3 lesions. Tumors with poor histologic factors or greater than T1 received adjuvant radiation (with or without 5-fluorouracil). Four patients developed a local failure at a median of 21.5 months (range, 9-30) and were salvaged with abdominoperineal resection. The 5-year cancer-specific survival was 91 per cent. Negative margins approached statistical significance (P < 0.07) in influencing local control. We conclude that, when combined with chemoradiation for lesions deeper than submucosa or with adverse histologic factors, local resection of rectal cancer is an effective treatment in selected patients.

Entities:  

Mesh:

Year:  1999        PMID: 10399970

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  TEMS: results of a specialist centre.

Authors:  S M Flexer; A C Durham-Hall; M A Steward; J M Robinson
Journal:  Surg Endosc       Date:  2014-01-11       Impact factor: 4.584

2.  Can CCRT/RT Achieve Favorable Oncologic Outcome in Rectal Cancer Patients With High Risk Feature After Local Excision?

Authors:  Seijong Kim; Jung Wook Huh; Woo Yong Lee; Seong Hyeon Yun; Hee Cheol Kim; Yong Beom Cho; Yoon Ah Park; Jung Kyong Shin
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

3.  Completion surgery vs. primary TME for early rectal cancer: a national study.

Authors:  William J Lossius; Tore Stornes; Tor A Myklebust; Birger H Endreseth; Arne Wibe
Journal:  Int J Colorectal Dis       Date:  2021-12-16       Impact factor: 2.571

4.  TEM in the treatment of recurrent rectal cancer in elderly.

Authors:  Stefano Perrotta; Gennaro Quarto; Vincenzo Desiato; Gianluca Benassai; Bruno Amato; Giacomo Benassai
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.